Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate

Clinical trial NCT00038675 · COMPLETED

Trial details

NCT number: NCT00038675
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Chronic Myelomonocytic Leukemia Chronic Myeloid Leukemia Polycythemia Vera Hypereosinophilic Syndrome Mastocytosis

Start date: 2001-06-01
Primary completion: 2013-11-01
Enrollment: 125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.